Identification and referral of women at risk for BRCA mutations.

被引:0
|
作者
Bellcross, Cecelia
Hermstad, April
Tallo, Christine L.
Leonard, Chelsea
Pencea, Ioana
Stanislaw, Christine L.
Kohlmann, Wendy
机构
[1] Emory Univ, Atlanta, GA USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
D O I
10.1200/JCO.2018.36.15_suppl.1514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1514
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
    Pruthi, Sandhya
    Gostout, Bobbie S.
    Lindor, Noralane M.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (12) : 1111 - 1120
  • [42] Hierarchical modeling in genetic epidemiology: Evaluating the spectrum of BRCA1 mutations.
    Witte, JS
    Eston, RC
    Greenland, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 41 - 41
  • [43] Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations.
    Moeslinger, R
    Wagner, T
    Langbauer, G
    Auterith, A
    Friedmann, A
    Zielinski, C
    Seifert, M
    Oefner, P
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A386 - A386
  • [44] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
    Boyoung Park
    James G. Dowty
    Choonghyun Ahn
    Aung K. Win
    Sung-Won Kim
    Min Hyuk Lee
    Jong Won Lee
    Eunyoung Kang
    John L. Hopper
    Sue K. Park
    Breast Cancer Research and Treatment, 2015, 152 : 659 - 665
  • [46] The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations
    Narod, Steven A.
    Metcalfe, Kelly
    Finch, Amy
    Chan, An-Wen
    Armel, Susan Randall
    Aeilts, Amber
    Eisen, Andrea
    Karlan, Beth
    Bordeleau, Louise
    Tung, Nadine
    Foulkes, William D.
    Neuhausen, Susan L.
    Eng, Charis
    Olopade, Olufunmilayo
    Zakalik, Dana
    Couch, Fergus
    Cullinane, Carey
    Pal, Tuya
    Sun, Ping
    Kotsopoulos, Joanne
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2024, 22 (01)
  • [47] Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2
    Goldfrank, Deborah
    Chuai, Shannon
    Bernstein, Jonine L.
    y Cajal, Teresa Ramon
    Lee, Johanna B.
    Alonso, M. Carmen
    Diez, Orland
    Baiget, Monserrat
    Kauff, Noah D.
    Offit, Kenneth
    Robson, Mark
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2311 - 2313
  • [48] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
    Park, Boyoung
    Dowty, James G.
    Ahn, Choonghyun
    Win, Aung K.
    Kim, Sung-Won
    Lee, Min Hyuk
    Lee, Jong Won
    Kang, Eunyoung
    Hopper, John L.
    Park, Sue K.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 659 - 665
  • [49] EXCELLENT EMBRYO DEVELOPMENT AND IVF OUTCOMES FOR PATIENTS WITH GERMLINE BRCA1 OR BRCA2 MUTATIONS.
    King, A.
    Hornberger, K. L.
    Young, D. O.
    Klepacka, D.
    Schoolcraft, W. B.
    Katz-Jaffe, M.
    FERTILITY AND STERILITY, 2016, 106 (03) : E373 - E374
  • [50] Identification and analysis of non-deletion dystrophin mutations.
    Austin, MA
    Korf, BR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A408 - A408